LeonaBio LONA
NASDAQ LONA
$7.70 -0.13 (-1.66%)
At close: Aug 20, 2026 · 4:00 PM EDT

LeonaBio (LONA) EPS (Basic) (2019 - 2026)

LeonaBio (LONA) posted quarterly EPS (Basic) of -$1.11 for Q1 2026, up 59.76% year-over-year from -$0.69 in Q1 2025, and up 94.11% quarter-over-quarter from -$18.85 in Q4 2025.

LeonaBio (LONA) EPS (Basic) (2019 - 2026) Analysis & Trends

LeonaBio (LONA) has reported EPS (Basic) for 8 consecutive years, with -$1.11 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) rose 59.76% year-over-year to -$1.11; the TTM figure through Mar 2026 stood at -$6.2 (up 86.41% YoY), while the FY2025 annual figure was -$24.7, up 1.92% from the prior year.
  • EPS (Basic) grew to -$1.11 in Q1 2026 per LONA's latest filing, from -$18.85 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$1.11 in Q1 2026 and bottomed at -$27.94 in Q4 2024.
  • Historically, EPS (Basic) has averaged -$8.47 across 5 years, with a median of -$7.73 in 2023.
  • Annual changes were most pronounced in 2024 — EPS (Basic) plunged 261.31% — and 2025, when it soared 75.33%.
  • LeonaBio's EPS (Basic) stood at -$8.83 in 2022, then increased by 12.44% to -$7.73 in 2023, then slumped by 261.31% to -$27.94 in 2024, then soared by 32.54% to -$18.85 in 2025, then soared by 94.11% to -$1.11 in 2026.
  • Business Quant data shows LONA's EPS (Basic) at -$1.11 in Q1 2026, -$18.85 in Q4 2025, and -$1.99 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.62
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.59
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.23
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.18
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 LeonaBio 182.69 Mn 131.62 Mn - -0.82

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.11
Dec 31, 2025 -18.85
Sep 30, 2025 -1.99
Jun 30, 2025 -2.15
Mar 31, 2025 -2.76
Dec 31, 2024 -27.94
Sep 30, 2024 -8.07
Jun 30, 2024 -7.47
Mar 31, 2024 -7.67
Dec 31, 2023 -7.73
Sep 30, 2023 -9.72
Jun 30, 2023 -8.87
Mar 31, 2023 -8.42
Dec 31, 2022 -8.83
Sep 30, 2022 -7.02
Jun 30, 2022 -6.47
Mar 31, 2022 -8.92
Dec 31, 2021 -5.09
Sep 30, 2021 -6.39
Jun 30, 2021 -6.54